Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,355Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6AstraZeneca Canada Inc.

02 8Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name : NAROPIN

Patent Number : 2165446

Filing Date : 1994-05-26

Strength per Unit : 2 mg/ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Infiltration/nerve block/epidural for injection

Patent Expiration Date : 2014-05-26

Date Granted : 2005-07-05

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name : NAROPIN

Patent Number : 2165446

Filing Date : 1994-05-26

Strength per Unit : 5 mg/ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Infiltration/nerve block/epidural for injection

Patent Expiration Date : 2014-05-26

Date Granted : 2005-07-05

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name : NAROPIN

Patent Number : 1337549

Filing Date : 1989-06-08

Strength per Unit : 5 mg/ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Infiltration/nerve block/epidural for injection

Patent Expiration Date : 2012-11-14

Date Granted : 1995-11-14

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name : NAROPIN

Patent Number : 1337549

Filing Date : 1989-06-08

Strength per Unit : 2 mg/ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Infiltration/nerve block/epidural for injection

Patent Expiration Date : 2012-11-14

Date Granted : 1995-11-14

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name : NAROPIN

Patent Number : 2165446

Filing Date : 1994-05-26

Strength per Unit : 10 mg/ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Infiltration/nerve block/epidural for injection

Patent Expiration Date : 2014-05-26

Date Granted : 2005-07-05

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name : NAROPIN

Patent Number : 1337549

Filing Date : 1989-06-08

Strength per Unit : 10 mg/ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Infiltration/nerve block/epidural for injection

Patent Expiration Date : 2012-11-14

Date Granted : 1995-11-14

blank

07

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name :

Patent Number : 1217773

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-02-10

Date Granted :

blank

08

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name :

Patent Number : 1217773

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-02-10

Date Granted :

blank

09

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name :

Patent Number : 1217773

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-02-10

Date Granted :

blank

10

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Ropivacaine Hydrochloride

Brand Name :

Patent Number : 1217773

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-02-10

Date Granted :

blank